gvtcx

NHSBT1067 - Hematopoietic Stem Cell Services for BBMR

NHS Blood & Transplant Published 16 Nov 2017 Contracts Finder

key details

Statusactive
Category (CPV) 85100000 +3 more
RegionLondon, South East
Deadline29 Dec 2017
Contract start1 Oct 2018
Contract end30 Sept 2020
Procedureselective
SME suitableNo
OCIDocds-b5fd17-8fedff7c-2ef1-4fba-878e-1b110c6d8028

description

The British Bone Marrow Registry (BBMR) is a division of NHS Blood and Transplant. The Northern Ireland and Scottish Blood Transfusion Services are participants in the service provided by the BBMR.

The BBMR supports HSC Clinical Transplantation Programmes for UK and International patients. It recruits prospective stem cell donors from the blood donor population. The donors are tissue typed and they are then available to be searched by accredited Transplant Centres or laboratories acting on their behalf for patients with leukaemia and other blood disorders. After further identification testing a donor may be selected as the final donor. The BBMR collects HSC products from donors between the ages of 18 and 60.

The finally selected donor is counselled and informed consent for the donation obtained. Donor counselling is currently performed by the BBMR in accordance with Human Tissue Authority (HTA) and World Marrow Donor Association (WMDA) requirements. Responsibility for this service can be undertaken by the service provider.

The donor must be medically assessed and fitness to donate the HSC product determined. The medical assessment of the donor includes the risk of disease transmission to the recipient.

The source of stem cells for First and Subsequent donations is from the Bone Marrow under General Anaesthetic (GA) as an inpatient, or Peripheral Blood stimulated by Granulocyte Colony Stimulating Factor (G-CSF) as an outpatient procedure. Subsequent donations for the same patient may also include blood lymphocytes.

For a peripheral blood stem cell collection donors receive a short course of G-CSF, 4 or 5 days. The successful contractor will prescribe G-CSF as Lenograstim, Granocyte®.

The service provider will procure, label and issue the HSC product, for distribution under direction from BBMR.

Additional information:

Expressions of Interest are required from suitably qualified and experienced suppliers able to deliver Hematopoietic Stem Cell Services for BBMR. All details regarding this requirement will be found on the Pre Qualification Questionnaire (PQQ), this will be published via Bravo Solutions on 23rd November 2017.

NHSBT will be running the Tender through Bravo Solutions ePortal, please follow the instructions below and email janice.allen@nhsbt.nhs.uk when you have completed the registration and to express your interest.

To register on our ePortal you need to follow these simple instructions.

To register your company on the eSourcing portal (this is only required once) - Browse to the eSourcing Portal at https://nhsbt.bravosolution.co.uk - Click the "Register now!" link - Accept the terms and conditions and click "continue" - Enter your correct business and user details - Note the username you chose and click "Save" when complete - You will shortly receive an email with your unique password (please keep this secure).

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
16 Nov 2017 Tender (tender) · e052d9c7-a9ab-410e-802c-e0c49a16cc47-182329

more from NHS Blood & Transplant

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.